Product
Lilly Bamlanivimab + Etesevimab
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
The UPMC OPtimizing Treatment and Impact of Monocolonal antIbodieS Through Evaluation for COVID-19 TrialStatus: Terminated, Estimated PCD: 2022-06-16